FDA clears the Focus Diagnostics SimplexaTM flu A/B & RSV direct test
Focus Diagnostics, the products business of Quest Diagnostics, announced that its Simplexa™ Flu A/B & RSV Direct Kit has received 510(k) clearance from the FDA for 46 additional influenza A and influenza B virus strains and 7 additional respiratory syncytial virus strains. October 06, 2015